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Abstract 
An 18 years old male was referred to us 4 years after major tumoral surgery. In 2002 he was diagnosed with 
Ewing  sarcoma  of  the  proximal  two-thirds  of  his  left  femur.  Wide  resection  of  the  tumor  was  performed,  with  a 
makeshift  implant  one-stage  reconstruction,  followed  by  a  combination  of  chemo  and  radiotherapy  for  another  6 
months. 
Eight months after surgery a deep infection of the hip developed, and despite antibiotic treatment and two 
consecutive debridments and lavage the results were negative. When we first saw the patient in 2006, he still had an 
active infection in his left hip and a septic general appearance. A two-stage revision was performed and a modular 
tumoral reconstruction was  implanted. At two years follow up the patient presents no signs of recurrence neither of the 
infection nor of the primary tumor. 
 
Replacement of bone segments after resection of a tumor-containing bone has a long history, 
and currently metallic implants and allografts have reasonable rates of success in terms of patient 
survival  and  restoration  of  useful  function.  Large  femoral  resections  for  extensive  tumors  are 
uncommon  but  clearly  represent  a  major  problem,  which  in  the  past  has  required  hip 
disarticulations. In recent years, resection and replacement using custom metallic implants and more 
recently modular devices have allowed the patients to be restored to reasonable function. 
An 18 years old male was referred to us 4 years after major tumoral surgery. In 2002 he was 
diagnosed with Ewing sarcoma of the proximal two-thirds of his left femur. Wide resection of the 
tumor was performed, with a makeshift implant one-stage reconstruction. 
The implant used for reconstruction was a combination of a long (275mm) Restoration DLS 
(Stryker Inc.) hip revision stem and a supracondylar nail. The DLS stem has two distal holes for 
femoral fixation. Two similar holes were drilled in the proximal end of the supracondylar nail and 
the two of them were bolted together. The distal part of the nail was secured in the remaining distal 
femur with intercondylar screws. A cemented acetabular cup was used (Fig. 1). 
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The reconstruction was successful, with preservation of the limb length and function, with 
partial weight-bearing three days after surgery and full weight bearing allowed at 4 weeks. 
In the mean time, a 6 months oncologic treatment involving chemo and radiotherapy was carried 
on. 
Initial results were encouraging, but at eight months after surgery signs of deep infection 
occurred. Despite of early antibiotherapy the infection progressed to an open active fistula in the 
proximal part of the hip. A large debridement and lavage was done leaving the implant in place but 
with  scarce  results.  Due  to  the  recurrence  of  the  infection  a  second  debridement  was  done  18 
months  later,  but  still  with  no  results.  In  both  cases  Coagulase-negative  Staphylococcus  was 
isolated from the site. 
After the second failed attempt to clear infection, a hip disarticulation was proposed to the 
patient and the family. They refused and were referred to our department for a second opinion. 
At admittance, the patient presented with an open fistula of the proximal part of the hip from which 
small  amounts  of  latescent  liquid  drained.  His  general  state  was  one  of  a  chronic  infection. 
Biologically  he  had  high  WBC  count,  elevated  ESR  (75/h)  and  3-times  above  normal  CRP. 
Procalcitonine test was positive. 
The A-P and lateral X-rays of the hip showed the femoral implant in place, with no signs of 
motion in the distal femur, but with radiolucent lines all around the acetabular cup (Fig. 2). 
 
 
 
Fig. 2: Radiolucent lines around the cup showing septic loosening. 
  
Coagulase-negative Staphylococcus was isolated from the site. 
After complete evaluation of the patient a two-stage revision-reconstruction of the hip was 
decided. The reasons for choosing these procedures were the age of the patient, the strong denial of 
a hip disarticulation and the qvasi-benign nature of the germ involved. The arguments against this 
procedure were the duration of the infection (3 years), previous failed surgeries and the lack of an 
appropriate hip spacer, which was the most acute problem we had. 
An external fixator was quickly excluded because of the large gap it had to cover and the 
presence of infection which could be maintained or worsened by subsequent pin site secondary 
sepsis, so we decided to use the old implant. 
In surgery an extended approach from the lateral aspect of the hip to the lateral side of the 
knee was performed. The acetabular cup and cement was removed along with the femoral implant. 
Large  debridement  was  done  followed  by  abundant  (20L)  saline  lavage.  The  femoral  implant 
looked stable and after thorough cleansing it was autoclaved for 45 min at 132ºC. After lavage 
Betadine swaps were left in place for 25 minutes followed by another abundant lavage. A new Journal of Medicine and Life  Vol. 1, No.4, October-December 2008 
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acetabular cup was inserted using antibiotic medicated cement and the femoral component was 
reinserted. A passive drainage was kept in place for 48 hours. 
After surgery a 6 weeks antibiotic regimen followed - Teicoplanin 400mg q.d. combined 
with Rifampicin 300mg b.i.d. 
The  postoperative  evolution  was  good,  with  primary  healing  of  the  wound  and  the 
normalization of the laboratory tests at 8 weeks. 
The patient was discharged free of infection awaiting the three months free interval to the 
final reconstruction.  
Unfortunately, after 2 months, the femoral implant broke were its components were bolted 
together, so the patient was placed in a hip cast with no weight bearing until final surgery. 
After one month there were no signs of septic recurrence and the final reconstruction with a 
HMRS (Stryker Inc.) femoral system was performed (Fig. 3). 
 
   
 
Fig.3: Final reconstruction with the HMRS system. 
 
At  one  year  follow  up  the  patient  has  no  signs  of  recurrent  sepsis  and  the  hip  function  is  91 
according to Harris Hip Score. No primary or secondary malignancies were noted. 
 
Discutions 
 
Prosthetic replacement following excision of a bone tumor can be complicated by infection 
because patients who undergo surgery for a neoplasic condition often are subjected to extensive 
soft-tissue dissection and long operating times and are immunosuppressed. 
The epidemiology, risk factors, and efficacy of therapy for infections complicating limb-
sparing surgery (LSS) are not understood completely. The treatment of infection in these patients is 
arduous and lengthy, with a substantial risk of amputation. 
Gaur and al. conducted in 2005 a study on one hundred three patients which underwent 104 
LSS  procedures.  Infections  at  the  LSS  site  occurred  in  26%  of  patients,  and  21%  of  patients 
developed  orthopedic  device  infections  (ODIs),  which  greatly  surpass  the  infection  rates  for 
conventional joint replacement.[3] Journal of Medicine and Life  Vol. 1, No.4, October-December 2008 
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Coagulase-negative  Staphylococcus  and  Staphylococcus  aureus  are  the  most  frequently 
involved in this cases.(94%)  
Studies in the literature suggest that two-stage revision can successfully treat the infection in 
72% of cases, but amputation to treat the infection go as high as 36%.[4,5] 
Antibiotics directed at all significant pathogens are required, ideally those with good activity 
against  adherent  bacteria  and  those  producing  a  biofilm,  e.g.  rifampicin  or  one  of  the 
fluoroquinolones. ODI requires antibiotic treatment for ≥6 weeks to several months in addition to 
surgery.[1] 
The effect of rifampicin in combination with various antibiotics has been very encouraging 
in clinical trials despite in vitro synergy and time–kill studies, which might appear to contradict 
this.[9]  It  is  particularly  useful  in  eradicating  bacteria  adherent  to  prosthetic  material  in  joint 
infection or chronic osteomyelitis.  
Rifampicin  has  excellent  anti-staphylococcal  activity  and  bioavailability,  can  penetrate 
white  blood  cells  to  kill  phagocytosed  bacteria  and  can  eradicate  adherent  organisms  in  the 
stationary phase making it the (almost) ideal antibiotic for bone infection. It has been shown to be 
particularly successful as an adjunct in PJI or osteomyelitis with metal pins in situ.[6,8] 
 
Conclusions 
 
Patients  treated  with  an  orthopaedic  procedure  for  an  oncological  condition  have  high 
infection rates. The treatment of infection in these patients is arduous and lengthy, with a substantial 
risk of amputation. 
Current treatment for bone malignancies is complicated by an unexpectedly high incidence 
of infection. ODI is the most common reason for amputation and poor functional outcomes. The 
identification of risk factors for ODI may allow modifications of therapy that reduce the incidence 
and severity of infection, but prevention of all ODIs will require novel strategies. 
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